CBG and CBD combined are shown to have increased anti-inflammatory, anti-oxidant effects, neuroprotective properties as well as improve energy, thinking and attention levels. Studies show they have potent pain-relieving effects that can replace NSAIDs⁴. They are found to be effective holistic treatments for the following conditions:

• Glaucoma¹
• Irritable bowel syndrome (IBS), ulcerative colitis and Crohn’s disease symptoms^2,3
• Bone fracture pain relief and healing⁴
• ADHD, anxiety, chronic fatigue³

CBG and CBD are also shown to restore neural loss and reduce neurodegeneration, neuroinflammation and oxidative stress. They are found to be effective for the following neurodegenerative disorders:

• Multiple sclerosis (MS)⁵
• Alzheimer’s disease⁶
• Huntington’s disease⁷
• Amyotrophic lateral sclerosis (ALS)⁸
• Parkinson’s disease⁹

CBG and CBD show promising research for various types of cancer, including some of the most aggressive cancers:

• Glioblastoma brain tumors^{10, 11}
• Breast cancer^{10, 11}
• Prostate cancer^{10, 11}
• Colorectal carcinoma^{10, 11}
• Gastric adenocarcinoma^{10, 11}

References:

1. Cannabinoids and glaucoma
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1772142/

2. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
https://pubmed.ncbi.nlm.nih.gov/23415610/

3. Nano-processed CBG/CBD effect on pain, adult attention deficit hyperactive disorder, irritable bowel syndrome and chronic fatigue syndrome
https://medcraveonline.com/IJCAM/IJCAM-14-00567.pdf

4. Cannabidiol and Cannabigerol, Nonpsychotropic Cannabinoids, as Analgesics that Effectively Manage Bone Fracture Pain and Promote Healing in Mice
https://pubmed.ncbi.nlm.nih.gov/37597163/

5. Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo
https://pubmed.ncbi.nlm.nih.gov/36830745/

6. Alzheimer’s disease; taking the edge off with cannabinoids?
https://pubmed.ncbi.nlm.nih.gov/17828287/

7. Neuroprotective properties of cannabigerol in Huntington’s disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice
https://pubmed.ncbi.nlm.nih.gov/25252936/

8. Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
https://pubmed.ncbi.nlm.nih.gov/31752240/

9. Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson’s disease using 6-hydroxydopamine-lesioned mice
https://pubmed.ncbi.nlm.nih.gov/33338634/

10. Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914500/

11. Cannabidiol (CBD) as a Promising Anti-Cancer Drug
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693730/